Comparison Overview
Fresenius Kabi Belgium
Fresenius Kabi Belgium
Brandekensweg 9, Schelle, Antwerpen 2627, BE
Last Update: 06/11/2025
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s produc...
Teva Pharmaceuticals
124 Dvora hanevi'a, Tel-Aviv, IL, 6944020
Last Update: 28/03/2026
Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicin...
Compliance Ranges Comparison
Fresenius Kabi Belgium
Teva Pharmaceuticals
Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Fresenius Kabi Belgium in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Teva Pharmaceuticals in 2026.
Incident History - Fresenius Kabi Belgium (X = Date, Y = Severity)
Fresenius Kabi Belgium cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Teva Pharmaceuticals (X = Date, Y = Severity)
Teva Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Fresenius Kabi Belgium
Teva Pharmaceuticals
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.